Projects per year
Fingerprint
Dive into the research topics where Department of Pharmacology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
3D BM for NK-AML interaction: Mimicking the bone marrow niche - 3D culture as a new tool to improve NK cell-based immunotherapies for AML
Witalisz-Siepracka, A. (PI) & Summer, S. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.07.2025 → 30.06.2028
Project: Funded Research
-
AGEs: Role of Dietary Glycation Products in Allergic Sensitization
Geiselhart, S. (PI)
01.09.2024 → 31.08.2026
Project: Funded Research
-
Breast Cancer: Uncovering new checkpoints in natural killer cells to prevent breast cancer metastasis
Witalisz-Siepracka, A. (PI), Vallet, S. (CoPI) & Gotthardt, D. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.12.2022 → 30.11.2026
Project: Funded Research
Research output
-
Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemia
Weiss, S., Zdársky, B., Witalisz-Siepracka, A., Edtmayer, S., Holzer, A., Heindl, K., Casanova, E., Podar, K. & Stoiber, D., 31 Mar 2025, In: Cancer Letters. 613, p. 217501 217501.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions
Karjalainen, A., Witalisz-Siepracka, A., Prchal-Murphy, M., Martin, D., Sternberg, F., Krunic, M., Dolezal, M., Fortelny, N., Farlik, M., Macho-Maschler, S., Lassnig, C., Meissl, K., Amenitsch, L., Lederer, T., Pohl, E., Gotthardt, D., Bock, C., Decker, T., Strobl, B. & Müller, M., Dec 2025, In: Cellular and Molecular Life Sciences. 82, 1, p. 98 98.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Citation (Scopus) -
Cyclin C promotes development and progression of B-cell acute lymphoblastic leukemia by counteracting p53-mediated stress responses
Trifinopoulos, J., List, J., Klampfl, T., Klein, K., Prchal-Murphy, M., Witalisz-Siepracka, A., Bellutti, F., Fava, L. L., Heller, G., Stummer, S., Testori, P., Den Boer, M. L., Boer, J. M., Marinovic, S., Hoermann, G., Walter, W., Villunger, A., Sicinski, P., Sexl, V. & Gotthardt, D., Apr 2025, In: Haematologica. 110, 4, p. 877-892 16 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Citation (Scopus)
Activities
-
The bright and dark sides of STAT3 in acute myeloid leukemia
Stoiber-Sakaguchi, D. (Speaker)
Oct 2025Activity: Talk or presentation › Science to science: (Invited) talk/oral presentation
-
STAT3 signaling in acute myeloid leukemia development and progression
Stoiber-Sakaguchi, D. (Speaker)
26 Sept 2025Activity: Talk or presentation › Science to science: (Invited) talk/oral presentation
-
Deciphering the function of natural killer cells in mutant calreticulin-driven myeloproliferative neoplasms
Witalisz-Siepracka, A. (Speaker)
24 Sept 2025Activity: Talk or presentation › Science to science: (Invited) talk/oral presentation
Prizes
Press/Media
-
Mit Stat3β gegen Akute Myeloische Leukämie
30.05.2024
1 Media contribution
Press/Media: Newspaper/magazine › Print
-
Die Killerzellen kämpfen lassen
28.05.2024
1 item of Media coverage
Press/Media: Newspaper/magazine › Online
-
60 Sekunden mit Agnieszka Witalisz | Krebsforschung
12.01.2024
1 item of Media coverage
Press/Media: Social media/Blog